Parametric Portfolio Associates’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
OAM
Parametric Portfolio Associates's ASTH Position: Q1 2022 in Review
Parametric Portfolio Associates reduced its Astrana Health (ASTH) stake by 10% in Q1 2022, selling an estimated $229K and leaving 39,101 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2445.
Parametric Portfolio Associates first reported a position in ASTH in Q2 2021 and has held it in 4 quarters since. The position peaked at $3.35M in Q3 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.
- Parametric Portfolio Associates held 39,101 shares of Astrana Health worth $1.9M as of Q1 2022.
- Parametric Portfolio Associates sold 4,434 Astrana Health shares in Q1 2022, an estimated $229K.
- Astrana Health made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2445 holding.
- Parametric Portfolio Associates first reported a position in Astrana Health in Q2 2021 and has held it in 4 quarters since.
- Parametric Portfolio Associates's Astrana Health position peaked at $3.35M in Q3 2021.
- 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.